CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of corneal disorders
3.4.1.2. High growth potential in emerging markets
3.4.1.3. Technological advancements in the field of cornea
3.4.2. Restraints
3.4.2.1. Shortage of corneal donors
3.4.3. Opportunities
3.4.3.1. Increase in geriatric population
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Penetrating keratoplasty
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Endothelial keratoplasty
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CORNEAL IMPLANTS MARKET, BY DISEASE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Keratoconus
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Fuchs’ dystrophy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Infectious keratitis
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: CORNEAL IMPLANTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ophthalmic centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CORNEAL IMPLANTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Procedure Type
7.2.3. Market size and forecast, by Disease Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Procedure Type
7.2.5.1.3. Market size and forecast, by Disease Type
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Procedure Type
7.2.5.2.3. Market size and forecast, by Disease Type
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Procedure Type
7.2.5.3.3. Market size and forecast, by Disease Type
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Procedure Type
7.3.3. Market size and forecast, by Disease Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Procedure Type
7.3.5.1.3. Market size and forecast, by Disease Type
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Procedure Type
7.3.5.2.3. Market size and forecast, by Disease Type
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Procedure Type
7.3.5.3.3. Market size and forecast, by Disease Type
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Procedure Type
7.3.5.4.3. Market size and forecast, by Disease Type
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Procedure Type
7.3.5.5.3. Market size and forecast, by Disease Type
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Procedure Type
7.3.5.6.3. Market size and forecast, by Disease Type
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Procedure Type
7.4.3. Market size and forecast, by Disease Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Procedure Type
7.4.5.1.3. Market size and forecast, by Disease Type
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Procedure Type
7.4.5.2.3. Market size and forecast, by Disease Type
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Procedure Type
7.4.5.3.3. Market size and forecast, by Disease Type
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Procedure Type
7.4.5.4.3. Market size and forecast, by Disease Type
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Procedure Type
7.4.5.5.3. Market size and forecast, by Disease Type
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Procedure Type
7.4.5.6.3. Market size and forecast, by Disease Type
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Procedure Type
7.5.3. Market size and forecast, by Disease Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Procedure Type
7.5.5.1.3. Market size and forecast, by Disease Type
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Procedure Type
7.5.5.2.3. Market size and forecast, by Disease Type
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Procedure Type
7.5.5.3.3. Market size and forecast, by Disease Type
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Procedure Type
7.5.5.4.3. Market size and forecast, by Disease Type
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Aurolab
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. AJL Opthalmic SA
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. CorneaGen
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. KeraMed, Inc
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Presbia Plc
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. CorNeat Vision
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Mediphacos
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. LinkoCare Life Sciences AB
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. EyeYon Medical
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. DIOPTEX
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
TABLE 01. GLOBAL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 02. CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)
TABLE 03. CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)
TABLE 04. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 06. CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. CORNEAL IMPLANTS MARKET FOR INFECTIOUS KERATITIS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 11. CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CORNEAL IMPLANTS MARKET FOR OPHTHALMIC CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CORNEAL IMPLANTS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. U.S. CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 20. U.S. CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 21. U.S. CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 22. CANADA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 23. CANADA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 24. CANADA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. MEXICO CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 26. MEXICO CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 27. MEXICO CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 29. EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 30. EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. EUROPE CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. GERMANY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 33. GERMANY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 34. GERMANY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. FRANCE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 36. FRANCE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 37. FRANCE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. UK CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 39. UK CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 40. UK CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. ITALY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 42. ITALY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 43. ITALY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. SPAIN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 45. SPAIN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. SPAIN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. JAPAN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 55. JAPAN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 56. JAPAN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CHINA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 58. CHINA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 59. CHINA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. INDIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 61. INDIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 62. INDIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. AUSTRALIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 65. AUSTRALIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 73. LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. LAMEA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 76. BRAZIL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 77. BRAZIL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 78. BRAZIL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 81. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 84. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 87. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. AUROLAB: KEY EXECUTIVES
TABLE 89. AUROLAB: COMPANY SNAPSHOT
TABLE 90. AUROLAB: PRODUCT SEGMENTS
TABLE 91. AUROLAB: PRODUCT PORTFOLIO
TABLE 92. AJL OPTHALMIC SA: KEY EXECUTIVES
TABLE 93. AJL OPTHALMIC SA: COMPANY SNAPSHOT
TABLE 94. AJL OPTHALMIC SA: PRODUCT SEGMENTS
TABLE 95. AJL OPTHALMIC SA: PRODUCT PORTFOLIO
TABLE 96. CORNEAGEN: KEY EXECUTIVES
TABLE 97. CORNEAGEN: COMPANY SNAPSHOT
TABLE 98. CORNEAGEN: PRODUCT SEGMENTS
TABLE 99. CORNEAGEN: PRODUCT PORTFOLIO
TABLE 100. KERAMED, INC: KEY EXECUTIVES
TABLE 101. KERAMED, INC: COMPANY SNAPSHOT
TABLE 102. KERAMED, INC: PRODUCT SEGMENTS
TABLE 103. KERAMED, INC: PRODUCT PORTFOLIO
TABLE 104. PRESBIA PLC: KEY EXECUTIVES
TABLE 105. PRESBIA PLC: COMPANY SNAPSHOT
TABLE 106. PRESBIA PLC: PRODUCT SEGMENTS
TABLE 107. PRESBIA PLC: PRODUCT PORTFOLIO
TABLE 108. CORNEAT VISION: KEY EXECUTIVES
TABLE 109. CORNEAT VISION: COMPANY SNAPSHOT
TABLE 110. CORNEAT VISION: PRODUCT SEGMENTS
TABLE 111. CORNEAT VISION: PRODUCT PORTFOLIO
TABLE 112. MEDIPHACOS: KEY EXECUTIVES
TABLE 113. MEDIPHACOS: COMPANY SNAPSHOT
TABLE 114. MEDIPHACOS: PRODUCT SEGMENTS
TABLE 115. MEDIPHACOS: PRODUCT PORTFOLIO
TABLE 116. LINKOCARE LIFE SCIENCES AB: KEY EXECUTIVES
TABLE 117. LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT
TABLE 118. LINKOCARE LIFE SCIENCES AB: PRODUCT SEGMENTS
TABLE 119. LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO
TABLE 120. EYEYON MEDICAL: KEY EXECUTIVES
TABLE 121. EYEYON MEDICAL: COMPANY SNAPSHOT
TABLE 122. EYEYON MEDICAL: PRODUCT SEGMENTS
TABLE 123. EYEYON MEDICAL: PRODUCT PORTFOLIO
TABLE 124. DIOPTEX: KEY EXECUTIVES
TABLE 125. DIOPTEX: COMPANY SNAPSHOT
TABLE 126. DIOPTEX: PRODUCT SEGMENTS
TABLE 127. DIOPTEX: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
